SUBSCRIBE
SUBSCRIBE

Foundation Medicine, Inc.

Foundation Medicine was founded in 2010 with a mission to bring deep molecular information to the point of care for every patient living with advanced cancer.

400 Summer Street, Boston, MA 02210
Visit website
NEWS
Heads Up Biotechs: Illumina Ventures Closes $230M
Genetown
Top 5 Massachusetts Biotechs That Jumped at Least 250% in 2017
Boston Business Journal pulled together a list of the 25 biggest gainers in the state for 2017, and five of them are biopharma companies.
December 11, 2017
 · 
4 min read
 · 
Mark Terry
Business
Former Foundation Medicine CEO Joins Ex-Googler’s All Male VC Firm
The addition of Pellini means the San Diego-based firm launched earlier this year can increase its investing pace and tap his healthcare experience as an executive at Foundation.
December 5, 2017
 · 
1 min read
Foundation Medicine Wins Approval From the FDA an
FDA
Foundation Medicine Wins Approval From the FDA and Medicare for First-of-Its-Kind Cancer Test
Foundation Medicine’s sequencing diagnostics test for solid tumors that can detect cancer-causing mutations in 324 genes was approved by the FDA Thursday.
November 30, 2017
 · 
2 min read
 · 
Alex Keown
Amneal and Impax to Marry, Creating the 5th Larges
Genetown
This is the Precision Medicine Biotech That’s Revolutionizing Cancer Treatment
Cancer treatment is moving rapidly toward personalized medicine and precision medicine thanks to genetic insight.
November 3, 2017
 · 
1 min read
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015
Drug Development
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015
March 23, 2016
 · 
3 min read
BioMidwest
Foundation Medicine, Inc.’s Social Network for Tumors Help Doctors Find A Match
May 29, 2015
 · 
1 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Roche Pays $1.03 Billion for Majority Stake in Foundation Medicine, Inc.
January 12, 2015
 · 
2 min read
Load More
JOBS
IN THE PRESS
FDA
U.S. Food and Drug Administration (FDA) Approves FoundationOne®Liquid CDx as a Companion Diagnostic for Pfizer’s BRAFTOVI® (encorafenib)
June 9, 2023
 · 
5 min read
Business
Foundation Medicine Announces Collaboration with Merck KGaA, Darmstadt, Germany to Develop Companion Diagnostics for Selected Marketed and Pipeline Treatments
June 5, 2023
 · 
4 min read
Genetown
Foundation Medicine Expands Monitoring Portfolio with Launch of FoundationOne®Monitor
June 2, 2023
 · 
3 min read
Genetown
Foundation Medicine and Its Collaborators Announce Acceptance of 21 Abstracts at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
May 26, 2023
 · 
14 min read
FDA
FoundationOne®Liquid CDx Receives FDA-Approval as a Companion Diagnostic for EXKIVITY® (mobocertinib) to Identify Patients with EGFR Exon 20 Insertion Mutations in Advanced Non-Small Cell Lung Cancer
May 4, 2023
 · 
11 min read
Business
Foundation Medicine and Bristol Myers Squibb Expand Partnership to Focus on Companion Diagnostic Development
April 11, 2023
 · 
3 min read
Genetown
Foundation Medicine to Share 10 Abstracts at AACR23 Demonstrating the Unique Capabilities of Its Molecular Profiling Tests to Advance Precision Cancer Care
April 5, 2023
 · 
5 min read
Business
Foundation Medicine Announces Global Collaboration with Boehringer Ingelheim to Advance Biliary Tract Cancer Care
January 19, 2023
 · 
4 min read
Business
Foundation Medicine Announces Collaboration with Karyopharm Therapeutics to Develop FoundationOne®CDx as a Companion Diagnostic for XPOVIO® (selinexor)
January 10, 2023
 · 
4 min read
Business
Foundation Medicine and Natera Announce the Launch of FoundationOne®Tracker Personalized Circulating Tumor DNA Monitoring Assay for Investigational Use and Early Access Clinical Use
January 9, 2023
 · 
7 min read
Load More